IP Library Granted Patent US 10,973,850
Granted Patent B2
US 10,973,850 · App. 15/542,336 · Granted Apr 13, 2021

Composition comprising tricalcium phosphate and gelatin for use in a method for the treatment of dyspepsia and related disorders

Inventor: Bruno Silvestrini (Rome, IT)
Assignee: Health Pharma S.p.A.
A61K33/42A61K9/0056A61K9/0095A61K9/20A61K9/2063A61K38/39A61K45/06A61K47/42A61P1/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,973,850
App. No.
15/542,336
Granted
Apr 13, 2021
Kind
B2
Abstract

A pharmaceutical composition comprising tricalcium phosphate and gelatin for use in a method for the treatment of dyspepsia, acidic mouth and and/or canker sores is disclosed.

Claims (9)

1. A composition for the treatment of dyspepsia, acidic mouth and/or canker sores, the composition comprising tricalcium phosphate and gelatin, wherein the ratio of tricalcium phosphate to gelatin is about 1:6, and wherein the composition is in the form of an oral dispersible tablet to swallow or in the form of a liquid to be administered by oral route.

2. The composition according to claim 1 , wherein the gelatin is of animal origin.

3. The composition according to claim 1 , wherein the gelatin is of fish origin.

4. The composition according to claim 1 , wherein the composition is in unit dose form comprising 1.5 g gelatin and 0.25 g tricalcium phosphate.

5. The composition according to claim 1 , wherein the gelatin is of animal origin; and wherein the composition is in unit dose form comprising 1.5 g gelatin and 0.25 g tricalcium phosphate.

6. The composition according to claim 1 further comprising at least one antacid and/or antisecretory agent.

7. The composition according to claim 1 , wherein the gelatin is of fish origin; and wherein the composition is in a unit dose form comprising 1.5 g gelatin and 0.25 g tricalcium phosphate.

8. A bottle with a spray dispenser for oral administration, comprising the composition according to claim 1 , wherein the composition is in liquid form and wherein the gelatin is of animal origin.

9. A bottle with a spray dispenser for oral administration, comprising the composition according to claim 1 , wherein the composition is in liquid form and wherein the gelatin is of fish origin.

Assignments (4)
MERGER AND CHANGE OF NAME Recorded Dec 30, 2021
From: HEALTH PHARMA S.P.A; HEALTH BIOSCIENCES S.P.A
To: BE HEALTH S.P.A
Reel/Frame 058509/0693 →
CHANGE OF NAME Recorded Feb 5, 2021
From: HEALTH PHARMA S.R.L.
To: HEALTH PHARMA S.P.A.
Reel/Frame 055237/0553 →
MERGER AND CHANGE OF NAME Recorded Feb 4, 2021
From: S.B.M. S.R.L.; SBM TRADING S.R.L.
To: HEALTH PHARMA S.R.L.
Reel/Frame 055148/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2017
From: SILVESTRINI, BRUNO
To: S.B.M. S.R.L.
Reel/Frame 043705/0128 →
Priority Claims (1)
EP 15425001 · Jan 9, 2015 · regional
Continuity (1)
Related Publication 20180271905A1 · Sep 27, 2018